Loading…
US stock · US markets · public data
MRNA
Moderna Inc · Healthcare
Reference price$198.88Updated according to the public source
P/E—
P/B11.74
ROE-39.00%
DY 12M—
Net margin-141.43%
Debt/equity0.19
Market capUS$ 79.4 B
Volume (shares)16,770,000
SectorHealthcare
Overview
Indicadores públicos consolidadosAbout MRNA
Moderna Inc (MRNA) is a stock traded in US markets in the Healthcare sector. P/E —, P/B 11.74, ROE -39.00% and dividend yield not disclosed. This page brings together the public indicators available for this asset. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
Distributions
public dataDividends and distributions · last 12 records
The source returned no recent distributions for this asset.
Financials
No dataIncome statement, balance sheet and cash flow
Financial statements are not available for this asset yet.
FAQ
Frequently asked questions
What is the price of MRNA?
The current price of MRNA is $198.88.
What is the P/B of MRNA?
The P/B of MRNA is 11.74, meaning the stock trades at 11.74 times its book value per share.
What is the ROE of MRNA?
The ROE (Return on Equity) of MRNA is -39.00%, meaning the company generates -39.00% of profit for every unit of shareholders' equity.
What is the market cap of MRNA?
The market capitalization of MRNA is US$ 79.4 B.
What is the net margin of MRNA?
The net profit margin of MRNA is -141.43%, meaning the company keeps -141.43% of revenue as profit.
What is the debt-to-equity ratio of MRNA?
The debt-to-equity ratio of MRNA is 0.19, meaning the company has 0.19 units of debt for each unit of equity.
What sector is MRNA in?
MRNA operates in the Healthcare sector.